4.2 Article

Fetal thrombocytopenia

Journal

SEMINARS IN FETAL & NEONATAL MEDICINE
Volume 13, Issue 4, Pages 223-230

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.siny.2008.02.008

Keywords

fetus; FNAIT; human platelet antigens; intracranial hemorrhage; thrombocytopenia

Categories

Ask authors/readers for more resources

Fetal thrombocytopenia is most often caused by maternal alloantibodies against fetal platelets crossing the placenta and resulting in platelet destruction. This condition, known as fetal and neonatal alloimmune thrombocytopenia, is usually detected after the birth of a symptomatic child who shows signs of bleeding in the skin or in the brain. In the most severe cases, intracranial hemorrhage leads to severe handicap or death. The challenge for the clinician is to provide preventive treatment in the next pregnancy. The current cornerstone of this treatment is maternal intravenous administration of immunoglobulins during the second half of pregnancy. (c) 2008 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available